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Ischemic stroke is characterized by permanent or transient obstruction of blood flow,
which initiates a cascading pathological process, starting from acute ATP loss and ionic
imbalance to subsequent membrane depolarization, glutamate excitotoxicity, and calcium
overload. These initial events are followed by neuroinflammation and oxidative stress,
eventually causing neuronal neurosis and apoptosis. Complicated interplays exist between
these steps happening across various stages, which not only represent the complicated
nature of ischemic pathology but also warrant a detailed delineation of the underlying
molecular mechanisms to develop better therapeutic options. In the present study, we
examined the neuroprotective effects of polydatin against ischemic brain injury using a rat
model of permanent middle cerebral artery occlusion (MCAO). Our results demonstrated
that polydatin treatment reduced the infarction volume and mitigated the neurobehavioral
deficits, sequentially rescued neuronal apoptosis. Ischemic stroke induced an elevation of
neuroinflammation and reactive oxygen species, which could be attenuated by polydatin
via the reduced activation of p38 mitogen-activated protein kinase and c-Jun N-terminal
kinase. In addition, polydatin upregulated the endogenous antioxidant nuclear factor
erythroid 2-related factor 2, heme oxygenase-1, the thioredoxin pathway, and eventually
reversed ischemic-stroke-induced elevation of ROS and inflammation in ischemic cortical
tissue. The diverse and broad actions of polydatin suggested that it could be a multiple
targeting neuroprotective agent in ameliorating the detrimental effects of MCAO, such as
neuroinflammation, oxidative stress, and neuronal apoptosis. As repetitive clinical trials
of neuroprotectants targeting a single step of stroke pathological process have failed
previously, our results suggested that a neuroprotective strategy of acting at different
stages may be more advantageous to intervene in the vicious cycles in MCAO.
Keywords: polydatin, ischemic stroke, neuroinflammation, oxidative stress, neuronal death
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INTRODUCTION

model (Cheng et al., 2006; Ji et al., 2012). Polydatin diminishes
infarct volume, reduces brain water, and improves neurologic
scores in focal cerebral ischemia (Cheng et al., 2006). Moreover,
the neuroprotective effect of polydatin in cerebral ischemia is
explored and attributed to several critical molecules involved
in inflammation and oxidative stress (Ji et al., 2012), suggesting
the biological activities of polydatin cannot be attributed to a
single pathway or receptor, but may involve a broad range of
pathological processes. Indeed, in renal ischemia, polydatin
exerts nephroprotective effects by PI3K/AKT signaling cascade
(Liu et al., 2015). In cardiac ischemia, polydatin attenuates
oxidative stress by renin–angiotensin system (RAS) and Rho
kinase (ROCK) pathways (Ming et al., 2017). In brain ischemia,
polydatin acts as neurotropic factor and activates BDNF
expression (Sun et al., 2014). Moreover, polydatin downregulates
cell adhesion molecules (CAMs) and modulates the migration
of inflammatory cell in cerebral ischemic injury (Cheng et al.,
2006). Numerous factors in ischemia sequentially mediate the
pathological processes, ranging from acute energy failure and
glutamate/calcium overload, to subacute neuroinflammation
and oxidative stress, eventually causes neuronal cell death.
Thus, future neuroprotective agents may warrant multiple steps
procedures, as various single target neuroprotective strategies
have been tested but yielded disappointing results.
The present study aims to evaluate whether polydatin’s effects
on neuroinflammation and oxidative stress could eventually
account for cellular protection. If so, the potential molecular
and cellular mechanisms underlying these effects still merit
further delineation. Results obtained will not only help us to
understand the cascading mechanisms eventually leading to
cell death, but also provide a clue as to the potentials of multiple
targeting therapeutics.

Stroke is the second leading cause of mortality worldwide
and ischemic stroke accounts for approximately 80% of stroke
incidence. Resulting from an occlusion of a major cerebral artery
[most often middle cerebral artery (MCA)] or its branches,
ischemic stroke is characterized by permanent or transient
obstruction of blood flow, impeding the delivery of oxygen and
essential nutrients to the brain. Tissue plasminogen activator
(tPA) is the only FDA-approved drug to reverse the adverse
effects of stroke by recanalizing obstructed vessels (i.e., the
vascular strategy for combating stroke). However, many clinical
limitations are associated with tPA administration, strengthening
the need for alternative therapeutic agents, in particular, natural
derived substances (Liu and McCullough, 2011).
Immediately after ischemia onset, a series of cascading
events occur which consequently contribute to the pathological
changes and clinical syndromes of stroke. Energy failure due
to diminished oxygen and glucose supply cause reduced ATP
and ionic imbalance, which subsequently results in membrane
depolarization and calcium overload. Glutamate over release
further facilitates calcium influx and initiates downstream
inflammatory and apoptotic mediators (Barone and Feuerstein,
1999; Wang et al., 2007). The inflammatory cascade occurs within
an hour after ischemic stroke and thus occupies a prominent
position in the pathophysiology of stroke (Wang et al., 2007;
Grønberg et al., 2013). Rapid activation of astrocytes and
microglial cells is followed by brain permeation of circulating
inflammatory cells, such as granulocytes and leukocytes (Chung
and Benveniste, 1990). Moreover, tissue damage due to blockade
of blood flow also initiates proinflammatory interleukin-1 (IL1β), tumor necrosis factor alpha (TNF-α), and interleukin-6
(IL-6), which were released instantly after ischemic onset and
are potential mediators of inflammation, compromising clinical
prognosis and increasing infarct volume in humans (Vila
et al., 2000).
Mitochondrial dysfunction and oxidative phosphorylation
decoupling happen early during ischemia and generate
numerous reactive oxygen species (ROS), leading to widespread
oxidative stress (Dirnagl et al., 1999). ROS like free radicals’
damage lipids, proteins, DNA, and cause intracellular organelle
destruction via plasma and organelle membrane peroxidation,
such as the endoplasmic reticulum and mitochondria. These
could further engender the release of biologically active free
fatty acids, such as arachidonic acid and DNA fragmentation.
Joined by the abovementioned energy failure, glutamate-induced
excitotoxicity, and inflammatory factors, the vicious cycles
induced by ROS eventually activate the injury pathways and lead
to cell necrosis and apoptosis.
Polydatin, also called piceid, is a traditional Chinese
medicine that has broad range of pharmacological activities,
including the anti-inflammatory and antiapoptotic activity
(Gao et al., 2016). The neuroprotective properties of polydatin
have been demonstrated in both cerebral ischemia and other
neurodegenerative diseases (Cheng et al., 2006; Xu et al.,
2016). Previous studies have shown that polydatin successfully
counteracts the deleterious effects of ischemic stroke in animal
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MATERIALS AND METHODS
Animal Grouping and Drug Treatment

Adult male Sprague–Dawley rats weighing 230 to 260 g, 7 to 10
weeks were purchased from Guangdong Medical Laboratory
Animal Center, China. The experimental animals were housed
at Laboratory Animal Research Center, Peking University
Shenzhen Graduate School, under 12 h light/12 h dark cycle at
18°C to 22°C and had free access to diet and tap water throughout
the study. The experimental procedures were set in such a way
to minimize rats suffering. All experimental procedures were
carried out according to the protocols approved by Institutional
Animal Care and Use Committee of Peking University Shenzhen
Graduate School. The rats were randomly divided into four
groups (n = 10–20/group): 1) Vehicle treated control group/
Sham; 2) Middle cerebral artery occlusion group/MCAO; 3) Rat
undergoing MCAO and treated with polydatin/Poly+MCAO; 4)
Sham-operated group and treated with polydatin/Poly+Sham.
Two doses of polydatin (30 mg/kg; Sigma) or vehicle were
administered intraperitoneally. The first dose was administered
30 min before ischemia, and the second dose was administered
within 1 h after ischemia, in accordance with previously reported
protocols (Cheng et al., 2006; Ji et al., 2012).
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Middle Cerebral Artery Occlusion Surgery

were optimized to the same threshold intensity for all groups for
pyknotic, red, and ghost neurons, while focusing specifically on
neuropil, neuronal size, and shape (frontal and piriform cortex).

MCAO was carried out as we have described previously (Shah
et al., 2014; Park et al., 2018). The two main branches of right
common carotid artery, external and internal carotid arteries,
were exposed. The two smaller braches of external carotid artery,
occipital artery and superior thyroid artery, were knotted with 6/0
black silk and subsequently pierced. A blue nylon filament (3/0)
approximately 30 mm in length had having a blunt, rounded tip
was inserted from the external carotid artery into internal carotid
artery and advanced further into the origin of the MCA. After
24 h of permanent occlusion, the animals were decapitated, and
brain tissues were collected. In sham-operated animals, all these
procedure were performed with exception of nylon insertion.

TUNEL Staining

Terminal deoxynucleotidyl transferase (TdT) dUTP Nick-End
Labeling (TUNEL) assay staining was performed with a commercial
kit according to the manufacturer’s protocol (Oncogene Research
Products, Cambridge, MA). The deparaffinized sections were
permeated with proteinase K, after which the peroxidases were
inactivated. The slides were subsequently incubated in equilibration
buffer with terminal deoxynucleotidyl transferase (TdT) labeling
reaction mixture at 37°C for 1.5 h. This reaction was stopped by
stopper buffer. The sections were washed with 0.1 M PBS and
stained in 3,3′-diaminobenzidine tetrahydrochloride (DAB) solution,
washed with distilled water, dehydrated in graded ethanol (70%,
95%, and 100%), fixed in xylene, and cover-slipped in mounting
medium. Immunohistochemical TIF images were captured with a
light microscope (five images per slide) and TUNEL-positive cells
were quantitated with ImageJ software. TIF images were optimized
to the same threshold intensity for all groups and was expressed as
the relative TUNEL neuronal cells/section of the samples relative to
the control (Shah et al., 2019).

Neurobehavioral Test

A five-point scale was used to describe neurologic deficit scores.
Rats showing no sign of injury received a score of 0, while a score
of 1 represented minor neurologic deficits. Moderate and severe
neurologic deficits, in which rats showed circling movements
(mild to spontaneous circling) with depressed consciousness,
were graded from 2 to 4. Rats receiving scores from 2 to 4 were
processed for further experimentation. Under this criterion,
seven rats were eliminated from further testing: five from group
2 and two from group 3.

Immunohistochemical Analysis

2,3,5-Triphenyltetrazolium Chloride
Staining and Histological Preparation

Immunohistochemical staining was performed as previously
described with minor modification (Sung et al., 2012). The slides
were processed for the antigen retrieval step (enzymatic method),
then washed with PBS. The endogenous peroxidase was quenched
by applying 3% hydrogen peroxide (H2O2) in methanol for 10 min.
The slides were incubated with 5% normal goat serum containing
0.1% Triton X-100. After being blocked, the slides were incubated
overnight in mouse anti-phosphorylated-c-Jun N-terminal kinase
(p-JNK), rabbit anti-IL-1β, rabbit anti-p-nuclear factor-κB (NFκB), and rabbit anti-iNOS antibodies (Santa Cruz Biotechnology,
Inc). The following morning, after being washed with 0.1-M PBS,
the slides were incubated in biotinylated secondary antibodies
according to the origin of the primary antibody and serum
used, then incubated with ABC reagents (SCBT USA) for 1 h in
a humidified chamber. The slides were washed with 0.1-M PBS,
stained in DAB solution, washed with distilled water, dehydrated
in a graded ethanol series, and cover-slipped in mounting
medium. P-JNK, IL1-β, p-NFKB, and iNOS in cortex/total area
were quantitatively determined as above.

After being evaluated for neurological deficits, rats were
decapitated under anesthesia, and brain tissues were carefully
removed. Three-millimeter-thick coronary sections were cut from
the frontal lobe with a sharp blade. Slices were incubated in 2%
2,3,5-triphenyltetrazolium chloride (TTC) for 10 to 20 min in a
water bath at 37°C until a thorough demarcation was observed, and
then fixed in 4% paraformaldehyde solution and photographed
(Shah et al., 2018). The infarct area was then measured with ImageJ
program and expressed as a percentage to total area.
To compensate for brain edema, the corrected brain infarction
was calculated as following:
Corrected infarct area = left hemisphere area − (right
hemisphere area − infarct area)
Brain sections were imbedded in paraffin, and 4-μm coronary
sections were made by using a rotary microtome. The slides were
deparaffinized in xylene and rehydrated in graded alcohol and
proceeded to the following staining techniques.

Immunofluorescence Analysis

Slides were treated with proteinase K (antigen retrieval step),
washed with 0.1 M PBS, and incubated with 5% normal serum
according to the source of the secondary antibody used. The
slides were incubated with primary antibodies against glial
fibrillary acidic protein (GFAP), TNF-α, ionized calcium-binding
adapter molecule 1(Iba-1), p-NF-κB, thioredoxin (TRX), and
8-oxoguanine (Santa Cruz Biotechnology, Inc), overnight at 4°C.
The next morning, after being washed with PBS, the slides were
incubated with fluorescently labeled secondary antibodies (Santa

Cresyl Violet Staining

Tissue slides were rinsed with distilled water and 0.1 M phosphate
buffer saline (PBS), and stained with 0.5% cresyl violet solution,
followed by rinsing with distilled water and differentiated in ethyl
alcohol (70%, 95%, and 100%). Brain slides were cleared with
xylene and mounted with a glass cover slip. The stained images were
pictured with light microscope (Olympus, Japan), saved as TIF files,
and analyzed by ImageJ computer-based program. The TIF images

Frontiers in Pharmacology | www.frontiersin.org

3

June 2019 | Volume 10 | Article 663

Shah et al.

Polydatin Attenuates MCAO Induced Neurodegeneration

Cruz Biotechnology) for signal amplification in a dark chamber,
then cover slipped in Ultra Cruz mounting medium (Santa Cruz
Biotechnology, Inc). Immunofluorescence images (five images
per slide) were captured using confocal scanning microscopes
(Flouview FV 1000; Olympus, Japan), and the same region of the
cortex/total area for all groups were quantitated as above.

receptor 4 (TLR4), anti-cycloxygenase-2 (COX2), anti-iNOS, anti-pNF-κB, anti-nuclear factor erythroid 2-related factor 2 (Nrf2), antiheme oxygenase-1 (HO-1), anti-TRX, and anti-β-actin (Santa Cruz,
Biotechnology, CA, USA), as well as anti-p-P38, P38 (Cell Signaling
Technology, CST).

Statistical Analysis

Western Blot Analysis

Western blot bands and immunohistochemical data were analyzed
using ImageJ software (ImageJ 1.30; https://imagej.nih.gov/ij/).
The data are presented as the means ± SEM, and neurological score
data are presented as the median and range. Data were analyzed
by one-way analysis of variance (ANOVA) followed by a post hoc
Bonferroni multiple comparison test using GraphPad Prism 5
software. In all analyses, differences were considered significant
at p < 0.05. The symbol ∗ indicates a significant difference relative
to sham, whereas shows a significant difference relative to MCAO.

This procedure was performed as previously described (Shah et al.,
2015), the samples were dissolved in lysis buffer (1 M Tris HCl, 5 M
sodium chloride, 0.5% sodium deoxycholate, 10% sodium dodecyl
sulfate, 1% sodium azide, 10% NP-40), and phenylmethylsulfonyl
fluoride (PMSF) was added as a protease inhibitor. The homogenate
was centrifuged, and the protein concentration was determined with
a bicinchoninic acid (BCA) kit (Pierce, Rockford, IL) according
to the guidelines provided by the manufacturer. Equals amount of
protein (i.e., 30 µg per sample) were electrophoresed on 10% sodium
dodecyl sulfate polyacrylamide gel electrophoresis (SDS-PAGE) gels
followed by immunoblotting to transfer the protein to polyvinylidene
fluoride (PVDF) membranes (Millipore, Billerica, MA). To minimize
nonspecific antibody binding, we blocked the PVDF membranes
with skim milk for 1 h at room temperature. The PVDF membranes
were washed in Tris-buffered saline containing 0.1% TWEEN
20 (TBST) and then incubated with primary antibodies overnight
at 4°C. The membranes were then incubated with appropriate
secondary antibodies, and the protein bands were detected using an
ECL detection reagent according to the manufacturer’s instructions
(Amersham Pharmacia Biotech, Piscataway, NJ). The antibodies
used include anti-p-JNK, JNK, anti-TNF-α, anti-IL-1β, anti-Toll-like

RESULTS
Effect of Polydatin on Neurological Scores,
Brain Infarction, and Neuronal Cell Loss

Neurological scores were determined 24 h after permanent MCAO.
Polydatin structure is illustrated in Figure 1A. Animals subjected
to MCAO exhibited severe neurological deficits ranging from
spontaneous circling (scores, 3 and 4) to depressed consciousness
(Shah et al., 2016). Treatment with polydatin attenuated these
scores, demonstrating that polydatin can mitigate neurological
deficits (p < 0.01, Figure 1B). The neocortex, caudate, and putamen

FIGURE 1 | Effect of polydatin on neurological scores, brain infarction and neurodegeneration. (A) Structure of polydatin. (B) Polydatin attenuated neurological
deficits. Neurological test was conducted 24 h after ischemia. Poly+MCAO rats had significantly improvement of neurological deficits (##p < 0.01) compared
to MCAO group. (C) Brain coronal sections were stained with TTC, which distinguishes between ischemic and non-ischemic areas (n = 5–10/group). (D)
Representative photomicrograph of cresyl violet staining showing the extent of surviving neurons in the cortex, scale bar = 50 μm. (a, b) Cytoplasmic swelling and
scalloped neurons with intense cytoplasmic eosinophilia and nuclear basophilia. These changes result from neuronal ischemia, which impairs metabolism in the
tissue. (c) Cytoplasmic fading of neurons, which invariably occurs in neurons at later stages of necrosis (ghost neurons). (d) Some cells had shrunken appearance
along with pyknotic nuclei. Intensive neuropil vacuolation can be seen in ischemic cortex (MCAO). ***p < 0.001; **, ##p < 0.01; #p < 0.05.
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were the most frequently damaged regions in this kind of ischemic
model (Shah et al., 2018). TTC staining entirely demarcated the
infarcted area from the deep red area of intact tissue (Figure
1C), with sham-operated rats showed no infarction. Polydatin
treatment reduced the size of infarction induced by MCAO (p <
0.01, Figure 1C).
To further examine, Nissl staining was used to reveal the extent
of neuronal injury in cortex. A substantial difference was observed
in the neuropil of ischemic cortex as compared with shamoperated control, where ischemia caused robust neuronal cell
loss in the cortex and polydatin treatment attenuated this damage
(Figure 1D, p < 0.05). Moreover, aberrant morphological neuronal
features were identified in the MCAO cortex, including alteration
in neuronal size and shape (swelling and a scalloped, angular
nature), alteration in color staining (cytoplasmic eosinophilia/
pyknosis, nuclear basophilia), and vacuolation (Figure 1D).

and ATP supply is severely depleted, or from induced apoptosis
mostly within the penumbra area. Depending on neuronal cell
type, condition, age, and brain location, necrotic and apoptotic
cell death pathways have broad crosstalk due to the common
triggers, including the calpains, nitric oxide, and poly ADP ribose
polymerase (PARP), which are not easily discernable based on
morphological changes. We then analyzed peri-infarct cortical
region as indicated by square 1 (Figure 2A). TUNEL staining was
performed to examine the apoptotic cells and the relative effect of
polydatin. Considerably, more TUNEL-positive cells were noticed
in the peri-infarcted area of the MCAO ipsilateral cortex (p < 0.001,
Figure 2B) than in that of poly+MCAO (p < 0.05, Figure 2B).
p38 MAPK and JNKs are important members of the MAPK
family involved in apoptotic pathways (Kyriakis and Avruch,
2012). Both JNK (as p-JNK) and p38 (as p-p38) activate apoptotic
cell death by transcriptional and posttranscriptional modification
(Xia et al., 1995). JNKs is critical in death receptor-initiated
extrinsic and mitochondrial elicited intrinsic apoptotic pathways,
whereas p38MAPK inhibition could protect against apoptosis
and necrosis in heart ischemia. To reveal the possible involvement
of p38 MAPK/JNK in polydatin’s protective effects against
apoptosis, Western blot analysis was performed to investigate

Effect of Polydatin on Neuronal Apoptosis
and Activation of the p38/JNK Pathways

Neuronal cell loss in ischemic injury may result either from necrosis
mainly in the core region, where blood flow is reduced by 90%

FIGURE 2 | Effect of polydatin on neuronal apoptosis and MAP kinase pathways. (A) TTC staining of coronal sections 24 h after permanent MCAO, separated
by frontal cortex (1), parietal cortex and insular cortex (2), and periform cortex (3). The analyzed peri-infarct region, region of interest indicated by square 1 (B)
Representative images of TUNEL histochemistry show apoptotic cells; scale bar = 100 μm. MCAO caused significant neuronal apoptosis, while polydatin treatment
attenuated apoptotic damage. Data presented are relative to Sham (n = 3–5/group). (C) Polydatin prevents MCAO-induced activation of p-p38 and p-JNK.
Representative Western blots of p-p38 and p-JNK (n = 5–8/group) and β-actin was used as a control. (D) Immunoreactivity of p-JNK; scale bar = 50 μm. p-JNK
exhibits cytoplasmic localization, and number of experiment performed = 3. ***p < 0.001; **p < 0.01; #p < 0.05.
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the activation of p38/JNK in cortical tissue after occlusion. The
results showed elevated expression of activated p38 and JNK in
MCAO group as compared with sham-operated controls, which
could be reduced by polydatin administration (Figure 2C).
These results were further validated by immunohistochemical
experiments as shown for p-JNK (Figure 2D).

Ischemic stroke is characterized by reactive gliosis in which
the residing microglia and astrocytes assume characteristic
cellular appearances to mediate progression of ischemic injury.
Following this, we investigated the involvement of astrocytic
(GFAP-reactive cells) and microglial activation (Iba-1-reactive
cells) in cortex. Immunofluorescence results revealed significant
increases in the numbers of GFAP- and Iba-1-reactive cells in
MCAO cortex compared with sham cortex, an effect that could
be downregulated by polydatin treatment (Figure 3A).
Both of these activated hypertrophic cells work as resident
machinery for generating inflammatory mediators and cytokines
that are implicated in ischemia (Chung and Benveniste, 1990;
Yu and Lau, 2000). Reports have consistently supported the
involvement of TLR4 in inflammation in ischemic brain injury
(Bowman et al., 2003; Caso et al., 2008). Western blot analysis was
performed to evaluate the expression of TLR4 24 h after permanent
MCAO. Our results showed that ischemic brain injury significantly
elevated the expression of TLR4, which could be effectively
decreased by polydatin (Figure 3B). Next, we examined the
expression levels of TNF-α and IL-1β, which increased within hours
after ischemia (Davies et al., 1999). Our results revealed that ischemic
brain injury significantly elevated their expression in ischemic

Polydatin Downregulates Ischemia-Related
Neuroinflammation

p38 is responsive to stress stimuli, such as inflammatory cytokines
and ROS. It is also involved in mediating cytokine production
including tumor necrosis factor-α (TNF-α), interleukin-1ß
(IL-1ß) in immune cells and regulating pro-inflammatory
signaling networks. JNK is involved in both adaptive and innate
immune response because it could be activated by various
proinflammatory cytokines, such as TNF and IL-1, and Tolllike receptor ligands. Moreover, a feedback mechanism exists
between inflammatory cytokines and activated p38/JNK,
in which activation of one pathway will activate the other,
suggesting critical roles of p38/JNK in inflammation (Nakajima
et al., 2004; Tu et al., 2011).

FIGURE 3 | Continued

Frontiers in Pharmacology | www.frontiersin.org

6

June 2019 | Volume 10 | Article 663

Shah et al.

Polydatin Attenuates MCAO Induced Neurodegeneration

FIGURE 3 | Polydatin attenuated reactive gliosis and inflammatory mediators in MCAO injury. (A) Immunoreactivity of astrocytes (GFAP-positive cells) in the
sham, MCAO, and Poly+MCAO groups are shown. Scale bar = 40 μm. The GFAP-positive cells were visualized by TRITC. Data presented are relative to
Sham and number of experiment performed = 3, and (n = 5–7/group). (B) Effect of polydatin on inflammatory cytokines. Western blot analysis of TLR4, TNFα,
and IL-1β (n = 5–8/group). The Western blots were quantified using ImageJ and analyzed by GraphPad Prism 5 software. β-Actin was used as a control.
(C) Immunohistochemistry results for IL-1β are shown; scale bar = 50 µm. (D) Double immunofluorescence reactivity of TNF and Iba-1. Scale bar = 20 μm. The
cortical sections show correspondingly elevated expression of TNF and Iba-1 after 24 h of permanent ischemia. TNF is visualized with FITC and IBa-1 by TRITC
(n = 5-7/group). ***p < 0.001; **, ##p < 0.01; #p < 0.05.

cortex compared with the sham-operated controls (Figure 3B).
The increasing effects of ischemic stroke could be reversed by
polydatin (Figure 3B). Likewise, immunohistochemistry of
IL-1β (Figure 3C) and double immunofluorescent colocalization
of TNF-α in Iba-1 immunopositive cells demonstrated higher
expression of both in the cortex of MCAO group (Figure 3D).
Polydatin treatment significantly decreased the expression of these
inflammatory markers (Figure 3C, D).

ischemic brain injury. To demonstrate the association between
inflammatory p-NF-κB and thioredoxin (TRX), a small thiolactive protein important for maintaining intracellular redox status
in the ischemic brain, we performed double immunofluorescence
(Figure 4C). Our results showed elevated expression of p-NF-κB
in ischemic cortex and correspondingly lower expression of TRX.
Treatment with polydatin significantly reduced the expression
of p-NF-κB while increasing TRX expression. Moreover, 8-
oxoguanine as an oxidative stress marker plays a vital role in the
pathogenesis of ischemic brain injury (Ali et al., 2015). We then
measured oxidative stress in ischemic brain by using 8-oxoguanine
fluorescence staining. Our results demonstrated elevated
expression of 8-oxoguanine in ischemic cortex, and this increase
would be attenuated by polydatin treatment (Figure 4D).
Nrf2 is a ubiquitously expressed transcription factor that
serves vital protective functions via regulating the expression
of various detoxifying and antioxidant process-related
proteins. Activated Nrf2 translocates to the nucleus and
stimulates transcription of several downstream antioxidant
proteins, such as HO-1, superoxide dismutase (SOD), and
glutathione (GSH). The migration pattern of Nrf2 on SDSPAGE electrophoresis is intensively debated. Recently,
it has been found that the Nrf2 band may be located at
approximately 90 to 110 kDa (Lau et al., 2013). Our Western

Effect of Polydatin on Oxidative Stress

Stress signals, such as proinflammatory factors TNFα, IL-1β, or
Toll, bind to their corresponding receptors that further link to
downstream molecules, involving the sequential activation of
ASK1, SEK1, and JNK. This process is followed by the proteasomemediated degradation of IκBs, activation, and nuclear translocation
of NF-κB, where it induces transcription of ROS generation-related
molecules, such as iNOS and COX2 (Yao et al., 2013). Accordingly,
Western blotting results showed elevated expression of these
mediators in ischemic brain (p < 0.01, Figure 4A), and polydatin
treatment significantly mitigated their expression (p < 0.05).
These results were further validated by immunostaining findings
for p-NF-κB and iNOS (Figure 4B). Activation of p-NF-κB
encodes the bulk of inflammatory mediators that exacerbate
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FIGURE 4 | Effect of polydatin on oxidative stress. (A) Western blot analysis of COX2, iNOS, and p-NF-κB (n = 5–8/group). The protein bands were quantified using
ImageJ and analyzed with GraphPad Prism 5 software. β-Actin was used as a control. Densitometric analysis was expressed in arbitrary units. (B) Representative
photos of immunohistochemistry for p-NF-κB and iNOS; scale bar = 50 µm. (C) Double immunofluorescence reactivity of p-NF-κB and TRX. Scale bar = 20 μm and
(n = 5–7/group). The ischemic tissue showed elevated expression of p-NF-κB and attenuated expression of TRX after 24 h of continuous ischemia. p-NF-κB and
TRX were visualized by FITC and TRITC, respectively. (D) Representative immunofluorescence images of 8-oxoguanine staining (n = 5–7/group). Scale bar = 50 μm.
(E) Polydatin treatment increased the levels of several antioxidant proteins in ischemic cortex. Western blot analysis of Nrf2, HO-1, and TRX (n = 5–8/group). The
protein bands were quantified using ImageJ and analyzed by GraphPad Prism 5 software. β-Actin was used as a control. ***p < 0.001; ##, **p < 0.01; #, *p < 0.05.

DISCUSSION

blot results demonstrated elevated expression of Nrf2 and
HO-1 in ipsilateral cortex after 24 h of permanent MCAO
relative to the sham controls, and polydatin significantly
attenuated this change (Figure 4E). Noticeably, we found a
high-intensity band for Nrf2 (90–120 kDa) and HO-1 in the
polydatin-treated group, with the same bands appearing at
low intensity in the sham group (Figure 4E).

Frontiers in Pharmacology | www.frontiersin.org

The present study demonstrated that polydatin treatment
attenuated neuronal cell loss in ischemia via rescuing apoptotic
cell death in MCAO, which are likely mediated by ameliorated
neuroinflammation, reduced oxidative stress, and enhanced
antioxidant mechanisms. Accumulation of toxic radicals,
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such as ROS triggered oxidative stress, is closely related
to neuroinflammatory activation, which further exacerbates
ischemic pathogenesis. Polydatin treatment had strong protective
effects not only through diminishing pro-neuroinflammatory
factors and p-NF-κB–mediated ROS generation, but also
strengthened intrinsic antioxidative mechanism, including
Nrf2, HO-1, and TRX. In clinical scenarios, thrombolytics,
such as activase and TNKase, remained the few available
pharmacological choices for clinical application, and the
usefulness of which is severely restricted within 3 to 4.5 h of
the onset of ischemia due to its short therapeutic window,
and thus, a limited patient can be benefited. Combination of
low-dose aspirin and other anti-coagulants is an established
prophylactic regime for stroke. However, the use of these
thrombolytics abolish only the occlusion but lack the efficacy to
attenuate tissue damage induced by ischemic injury. Therefore,
neuroprotective agents are required to stabilize the physiological
function of brain. As repetitive clinical trials of neuroprotectants
targeting a single step of stroke pathological process have failed
previously, polydatin in this study ameliorated the detrimental
effects of MCAO by targeting multiple stages of stroke, such as
neuroinflammation, oxidative stress, and neuronal apoptosis.
Our results demonstrated that a neuroprotectant acting at
different stages may be more advantageous to intervene in the
vicious cycles in MCAO.
Inflammation worsens the clinical prognosis of stroke and
compromises its therapeutic outcome. Stroke triggers both
resident and peripheral cells to migrate to the brain parenchyma
and contribute to inflammatory pathogenesis (Grønberg et al.,
2013). Release of inflammatory mediators substantiates ischemiainduced neuronal death by several mechanisms. First, activation
of TLR-4 on glial cells stimulates stress-related kinases, such
as JNK and p38-MAPK (Kacimi et al., 2011), whose activation
triggers the mitochondrial apoptotic pathway. Second, following
these kinases activation, inflammatory cytokines are produced
largely by activated microglia, astrocytes, and neurons within
the first hour after ischemic injury (Rothwell, 1991; Putcha et al.,
2003; Munoz et al., 2007; Wang et al., 2012). Third, activated
nuclear transcriptional machinery like NF-κB ultimately elicits
the production of pro-inflammatory factors, such as TNFα,
IL-1β, and nitric oxide, further aggregating the damage by the
initial pathological stimuli. The higher expression of NF-κB and
TLR-4 in our study was in agreement with previous reports that
TLR-4 receptors have cytotoxic roles in ischemic brain injury,
and TLR-4 knockdown is linked to reduced infarction area (Caso
et al., 2007).
It has been reported that NF-κB activation by TLR-4 triggers
iNOS, COX-2 production (Yao et al., 2013). Both COX-2 and
iNOS are toxic mediators of inflammatory cascade whose activity
can be down-regulated by inhibiting TLR-4 (Caso et al., 2007).
In accordance to results from other models, polydatin attenuates
ischemia-induced expression of TLR4, NF-κB, COX-2, iNOS,
indicating its anti-inflammatory effects (Huang et al., 2017; Tang
et al., 2018). In our study, ROS activity in ischemic cortex were
assessed using 8-oxoguanine as marker. Increased 8-oxoguanine
expression in ischemic tissue was significantly attenuated by
polydatin, showing the antioxidant nature of polydatin in our
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ischemic model. The detailed molecular mechanisms undying
polydatin’s effects are yet unknown but could be partially
attributed to its free radical scavenging properties. Recently
published data demonstrated that polydatin administration is
highly useful to cope against various models of (both in vivo
and in vitro) toxicities, or against neuronal death in numerous
kinds of ischemic models (Cheng et al., 2006; Zhang et al., 2012;
Ji et al., 2012).
Interestingly, a strong correlation between inflammation
and oxidative stress is demonstrated in both neuronal and
nonneuronal models (Yeligar et al., 2010; Ali et al., 2018).
Studies reiterating the free radical scavenging and antioxidant
profile of polydatin show that polydatin treatment restores
several antioxidant enzymes in different disease models (Qiao
et al., 2016). Thus, the ubiquitous anti-oxidative approach of
polydatin can be largely attributed to its mobilizing endogenous
antioxidant systems, such as activation of SODs, GSH, sirtuins
(Sirt), Nrf2/HO-1. Indeed, previous studies demonstrate that
polydatin is a potent activator of Sirt1, Sirt3, Sirt6, which are
involved in various cellular processes including cell survival
by promoting SOD and other antioxidant proteins (Caso et al.,
2007). One recent study suggested polydatin induces SIRT1Nrf2 pathway, as is also true for other polyphenol substances
(Huang et al., 2015; da Cunha and Arruda, 2017). TRX is an
antioxidant protein that participates in the eradication of ROS,
reducing apoptosis and excitotoxicity in ischemic brain injury.
As a stress sensor, cytoplasmic TRX has a strong inhibitory
effect on NF-κB nuclear translocation (Schenk et al., 1994;
Hirota et al., 1999). Our double immunofluorescence results,
as were also elaborated in the Western blot results showed
that ischemic injury attenuated the expression of TRX but
increased the nuclear translation of activated NF-κB. Polydatin
treatment reserved TRX activity and downregulates NF-κB.
Nrf2 is a physiological antioxidant sensor that dimerizes with
Keap1. Upon activation, Nrf2 is set free to translocate to the
nucleus and induce other antioxidant genes, such as HO-1
and SOD (Jung and Kwak, 2010). Increased Nrf2 and HO-1
activity begin immediately after ischemia and continue for
24 h (Yang et al., 2009). Polydatin increased the expression
of these antioxidant proteins in ischemic cortex, which was
also supported by a recent finding that overexpression of Nrf2
and HO-1 bolsters the endogenous defense machinery that
competes against oxidative stress in ischemic models (Yang
et al., 2009).
In conclusion, MCAO injury activates several proinflammatory
mediators including NF-κB and is further linked to ROS
generation. Polydatin attenuated MCAO-induced oxidative stress
and inflammatory cascade, possibly by modulating ROS/Nrf2/
TRX and TLR4/NF-κB pathway, eventually accounting for its
neuroprotective effects against neuronal apoptosis.
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